• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Clinical Significance of Spontaneous Echo Contrast on Extracorporeal Membrane Oxygenation
Conclusions SEC on VA-ECMO resulted in an increased risk of intracardiac thrombus and stroke. Maintaining pulsatility while the patient is on ECMO may result in a decreased chance of developing SEC and stroke.
Source: The Annals of Thoracic Surgery - February 16, 2017 Category: Cardiovascular & Thoracic Surgery Source Type: research

Novel Rotational Speed Modulation System Used With Venoarterial Extracorporeal Membrane Oxygenation
Conclusions Our system enabled an increase in coronary arterial flow and a decrease in LV work load and afterload during VA-ECMO. The system offers the effects of VA-ECMO and an IABP in a single device.
Source: The Annals of Thoracic Surgery - July 12, 2017 Category: Cardiovascular & Thoracic Surgery Source Type: research

SynCardia Temporary Total Artificial Heart as Bridge to Transplantation: Current Results at La Pitie Hospital ORIGINAL ARTICLES: ADULT CARDIAC
Conclusions The SynCardia t-TAH provided acceptable survival to transplantation rates with a remarkably low incidence of neurologic events. Posttransplant survival was similar to that of patients undergoing primary heart transplantation in France.
Source: The Annals of Thoracic Surgery - April 30, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Kirsch, M. E. W., Nguyen, A., Mastroianni, C., Pozzi, M., Leger, P., Nicolescu, M., Varnous, S., Pavie, A., Leprince, P. Tags: Mechanical Circulatory Assistance ORIGINAL ARTICLES: ADULT CARDIAC Source Type: research

Preoperative Venoarterial Extracorporeal Membrane Oxygenation Slashes Risk Score in Advanced Structural Heart Disease
ConclusionsECMO can be used as a bridge to heart valve or septal defect surgery in severely decompensated patients. Through recovery of end-organ function, ECMO may allow surgical correction of structural heart disease in patients considered inoperable or convert a salvage situation to an elective operation.
Source: The Annals of Thoracic Surgery - September 18, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships
ConclusionsWith the evolution of MCS, patient phenotype and outcomes are also changing over time. CF LVAD support is increasingly being used in the less ill patient phenotype and more patients are supported for destination therapy. Mean survival is now approaching 5 years, but adverse events, especially neurologic events, continue to have a detrimental impact on the success of CF LVAD support.
Source: The Annals of Thoracic Surgery - January 26, 2019 Category: Cardiovascular & Thoracic Surgery Source Type: research